GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yantai Dongcheng Biochemicals Co Ltd (SZSE:002675) » Definitions » Debt-to-Equity

Yantai Dongcheng Biochemicals Co (SZSE:002675) Debt-to-Equity : 0.19 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Yantai Dongcheng Biochemicals Co Debt-to-Equity?

Yantai Dongcheng Biochemicals Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ¥523 Mil. Yantai Dongcheng Biochemicals Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ¥336 Mil. Yantai Dongcheng Biochemicals Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ¥4,480 Mil. Yantai Dongcheng Biochemicals Co's debt to equity for the quarter that ended in Dec. 2024 was 0.19.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Yantai Dongcheng Biochemicals Co's Debt-to-Equity or its related term are showing as below:

SZSE:002675' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.07   Med: 0.21   Max: 0.41
Current: 0.19

During the past 13 years, the highest Debt-to-Equity Ratio of Yantai Dongcheng Biochemicals Co was 0.41. The lowest was 0.07. And the median was 0.21.

SZSE:002675's Debt-to-Equity is ranked better than
59.07% of 816 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs SZSE:002675: 0.19

Yantai Dongcheng Biochemicals Co Debt-to-Equity Historical Data

The historical data trend for Yantai Dongcheng Biochemicals Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yantai Dongcheng Biochemicals Co Debt-to-Equity Chart

Yantai Dongcheng Biochemicals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.23 0.13 0.16 0.19

Yantai Dongcheng Biochemicals Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.19 0.20 0.19 0.19

Competitive Comparison of Yantai Dongcheng Biochemicals Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Yantai Dongcheng Biochemicals Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yantai Dongcheng Biochemicals Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yantai Dongcheng Biochemicals Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Yantai Dongcheng Biochemicals Co's Debt-to-Equity falls into.


;
;

Yantai Dongcheng Biochemicals Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Yantai Dongcheng Biochemicals Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Yantai Dongcheng Biochemicals Co's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yantai Dongcheng Biochemicals Co  (SZSE:002675) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Yantai Dongcheng Biochemicals Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Yantai Dongcheng Biochemicals Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Yantai Dongcheng Biochemicals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 7 ChangBaishan Road, Yan Tai Development Zone, ShanDong, CHN, 264006
Yantai Dongcheng Biochemicals Co Ltd is a biochemical analytical profile index (API) manufacturers in China. In addition, the company also focuses on the development of finished preparation which covers the therapeutic area of cardiovascular, oncology, orthopedics, and anti-infection. Its product offering includes heparin sodium, chondroitin sulfate, marine collagen, hyaluronic acid, glucosamine, heparinoids, and cytochrome C. The company's API products have been exported to more than fifty countries and regions, including the United States of America, Germany, Austria, and Japan.
Executives
Xin Hong Bo Directors, executives
Luo Zhi Gang Executives
You Shou Yi Directors, executives
Lv Chun Xiang Supervisors
Sun Hong Tao Supervisors
Yi Qiong Executives
Yang Zhen Qiu Executives
Bai Xing Hua Directors, executives
Song Zhao Long Supervisors
Wen Lei Director
Zhu Chun Ping Executives
Qi Dong Qi Directors, executives
Liu Xiao Jie Securities Affairs Representative
Wang En Zheng Independent director
Shi Tao Supervisors

Yantai Dongcheng Biochemicals Co Headlines

No Headlines